预测头颈部癌症根治性或辅助性放疗联合全身治疗后早期死亡风险的列线图
研究基于美国国家癌症数据库2004至2017年接受放疗联合全身治疗的非转移性头颈部鳞癌患者,构建预测早期死亡(放疗开始后90天内死亡)的列线图。根治组84563例早期死亡率为3.5%(95%CI 3.4-3.7%),辅助组18514例为2.2%(95%CI 1.9-2.4%)。包含年龄、合并症、T和N分期及肿瘤部位的列线图预测效能优于单纯年龄。
要点
- 根治组84563例早期死亡率为3.5%(95%CI 3.4-3.7%),辅助组18514例为2.2%(95%CI 1.9-2.4%)。
- 年龄、合并症、T和N分期及肿瘤部位在两个队列中均与早期死亡相关(p < 0.05)。
- 列线图预测早期死亡的AUC在根治组为0.70 vs 年龄0.66,辅助组为0.71 vs 年龄0.61。
核心结论
- 包含年龄、合并症、T和N分期及肿瘤部位的列线图可用于预测根治性或辅助性放化疗后的早期死亡风险。
研究设计与样本
- 研究纳入美国国家癌症数据库2004至2017年接受根治性或辅助性放疗联合全身治疗的非转移性头颈部鳞状细胞癌患者。
- 采用多变量逻辑回归分析协变量与早期死亡的关系,并分别构建根治性和辅助性治疗场景的列线图。
主要发现
- 根治组84563例患者早期死亡率为3.5%(95%CI 3.4-3.7%),辅助组18514例患者为2.2%(95%CI 1.9-2.4%)。
- 年龄超过70岁的患者中,根治组早期死亡率为7.8%(95%CI 7.3-8.2%),辅助组为4.4%(95%CI 3.6-5.4%)。
- 多变量分析显示,年龄、合并症、T和N分期及肿瘤部位在两个队列中均与早期死亡相关(p < 0.05)。
- 列线图预测早期死亡的AUC在根治组为0.70,年龄为0.66;在辅助组列线图为0.71,年龄为0.61。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE/OBJECTIVES: We sought to create nomograms to predict individual risk of early mortality, which can identify patients who require interventions to prevent early death. METHODS: We included patients in the National Cancer Database with non-metastatic squamous cell carcinoma of the head and neck who received radiation and systemic therapy between 2004 and 2017 in the definitive or adjuvant setting. Early mortality was defined as any death less than 90 days after starting radiation. Multivariable logistic regression was used to assess the relationship between covariates and early mortality. Nomograms to predict the risk of early death were created for both the definitive and adjuvant settings. RESULTS: Among 84,563 patients in the definitive group and 18,514 patients in the adjuvant group, rates of early mortality were 3.5 % (95 % CI 3.4-3.7 %) and 2.2 %, (95 % CI 1.9-2.4 %), respectively. Patients above the age of 70 had an early mortality rate of 7.8 % (95 % CI 7.3-8.2 %) in the definitive group and 4.4 % (95 % CI 3.6-5.4 %) in the adjuvant group. In the multivariable analysis, age, comorbidity, T and N category, and tumor site were associated with early mortality in both cohorts (p < 0.05 for all). Nomograms including age, comorbidity, T and N category and tumor site performed better than age alone at predicting early mortality (AUC for definitive group: 0.70 vs 0.66; AUC for adjuvant group: 0.71 vs 0.61). CONCLUSION: Nomograms including age, comorbidity, T and N category and tumor site were developed to predict the risk of early death following definitive or adjuvant chemoradiation.
引用
- Raab G, Yu Y, Sherman E, et al. Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer. Clin Transl Radiat Oncol. 2024. PMID: 38304239. doi:10.1016/j.ctro.2024.100725
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。